# Recipharm Pharmaservices Private Limited, Bengaluru, India – FDA Inspections

Source: https://www.keypedia.com/companies/recipharm-pharmaservices-private-limited/cb3eebaa-2270-4301-a4a2-3ce95d076cd6

> Inspection records and compliance data for Recipharm Pharmaservices Private Limited in Bengaluru. 9 FDA inspections on record, 4 Form 483s, last inspected March 22, 2024.

---

## Details

- Name: Recipharm Pharmaservices Private Limited
- FEI Number: 3009150119
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: And 1108/970/1, 845/713 Khata No; Tumkur Road; Teppada Begur
- City: Bengaluru
- Country Name: India
- Address: And 1108/970/1, 845/713 Khata No; Tumkur Road; Teppada Begur, Bengaluru, India
- Country: India

## Related Documents

- FDA Inspection 1232473 - Recipharm Pharmaservices Private Limited - 2024-03-22 — classification: No Action Indicated (NAI), source: FDA, date: March 22, 2024
- [483 - Recipharm Pharmaservices Private Limited - 2020-02-13](https://www.keypedia.com/records/483/recipharm-pharmaservices-private-limited/526cedaa-2184-4035-ba1a-74360cb81877) — source: FDA, date: February 13, 2020
- [FDA Inspection 1119410 - Recipharm Pharmaservices Private Limited - 2020-02-13](https://www.keypedia.com/records/fda_inspections/recipharm-pharmaservices-private-limited/dd1ea548-d66a-4309-8ac5-8fe1a089153a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 13, 2020
- [483 - Recipharm Pharmaservices Private Limited - 2019-02-01](https://www.keypedia.com/records/483/recipharm-pharmaservices-private-limited/1feb07d0-7f4e-4d1f-84ed-d09c3c08c0c4) — source: FDA, date: February 1, 2019
- FDA Inspection 1079034 - Recipharm Pharmaservices Private Limited - 2019-02-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 1, 2019
- [FDA Inspection 1079034 - Recipharm Pharmaservices Private Limited - 2019-02-01](https://www.keypedia.com/records/fda_inspections/recipharm-pharmaservices-private-limited/ff968ebc-40dd-49c7-84d3-8d2080f8bc3c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 1, 2019
- [FDA Inspection 1075220 - Recipharm Pharmaservices Private Limited - 2018-12-07](https://www.keypedia.com/records/fda_inspections/recipharm-pharmaservices-private-limited/81f340a5-0e74-4b18-8dbb-cf65934bd357) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 7, 2018
- [FDA Inspection 1053644 - Recipharm Pharmaservices Private Limited - 2018-05-11](https://www.keypedia.com/records/fda_inspections/recipharm-pharmaservices-private-limited/a2baf591-c4b2-4164-9b3b-be80c923d53e) — classification: No Action Indicated (NAI), source: FDA, date: May 11, 2018
- [FDA Inspection 1037690 - Recipharm Pharmaservices Private Limited - 2017-12-14](https://www.keypedia.com/records/fda_inspections/recipharm-pharmaservices-private-limited/0f338ab7-111a-4a18-a919-9a24011077df) — source: FDA, date: December 14, 2017
- FDA Inspection 1002513 - Recipharm Pharmaservices Private Limited - 2017-02-09 — source: FDA, date: February 9, 2017
- FDA Inspection 921695 - Recipharm Pharmaservices Private Limited - 2015-03-19 — classification: No Action Indicated (NAI), source: FDA, date: March 19, 2015
- FDA Inspection 805946 - Recipharm Pharmaservices Private Limited - 2012-11-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 1, 2012

## Related Companies

- [Macleods Pharmaceuticals Limited](https://www.keypedia.com/companies/macleods-pharmaceuticals-limited/784654e5-6e07-47f7-9806-dd8c32db2e1d)
- [Wasserburger Arzneimittelwerk GmbH](https://www.keypedia.com/companies/wasserburger-arzneimittelwerk-gmbh/01756512-83f0-4432-8ab4-ea57cec1dfcc)
- [Teh Seng Pharmaceutical Mfg. Co., Ltd. 3rd Plant](https://www.keypedia.com/companies/teh-seng-pharmaceutical-mfg-co-ltd-3rd-plant/410dc182-1791-459c-8b4b-afa1aa9fbc49)
- [Organon Pharma (UK) Ltd.](https://www.keypedia.com/companies/organon-pharma-uk-ltd/5fa8cf74-45d3-45f6-abb3-6918d01961a6)
- [LEO Pharma Ireland](https://www.keypedia.com/companies/leo-pharma-ireland/59203974-017b-455b-b585-13cd35d25ed9)
- [Sun Pharmaceutical Industries, Inc.](https://www.keypedia.com/companies/sun-pharmaceutical-industries-inc/1a56d6cb-288c-42d5-9558-e4301ffebc65)
- [Padagis US LLC](https://www.keypedia.com/companies/padagis-us-llc/d356236a-0058-4d8b-86ad-56011f641c96)
- [King Pharmaceuticals LLC](https://www.keypedia.com/companies/king-pharmaceuticals-llc/d90c79dd-4325-4185-bf42-87c7f116f6c5)
- [OrBion Pharmaceuticals Private Limited](https://www.keypedia.com/companies/orbion-pharmaceuticals-private-limited/1cdc049d-587c-4283-8d5c-8604cff032c9)
- [Hikma Farmaceutica, (Portugal) S.A.](https://www.keypedia.com/companies/hikma-farmaceutica-portugal-sa/39ec9f09-5b00-4a12-aa9b-2add04e825e0)

## Related Officers

- [Supervisory Consumer Safety Officer, China Office](https://www.keypedia.com/people/marcus-a-ray/d394d757-5569-4697-bec1-c24113e29d6f)
- [Jason R. Caballero](https://www.keypedia.com/people/jason-r-caballero/c2c8d281-0d02-459f-9541-bc04cb6d0a59)
